389 related articles for article (PubMed ID: 25670067)
1. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
Van Belle E; Rauch A; Vincentelli A; Jeanpierre E; Legendre P; Juthier F; Hurt C; Banfi C; Rousse N; Godier A; Caron C; Elkalioubie A; Corseaux D; Dupont A; Zawadzki C; Delhaye C; Mouquet F; Schurtz G; Deplanque D; Chinetti G; Staels B; Goudemand J; Jude B; Lenting PJ; Susen S
Circ Res; 2015 Mar; 116(7):1193-201. PubMed ID: 25670067
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
Van Belle E; Rauch A; Vincent F; Robin E; Kibler M; Labreuche J; Jeanpierre E; Levade M; Hurt C; Rousse N; Dally JB; Debry N; Dallongeville J; Vincentelli A; Delhaye C; Auffray JL; Juthier F; Schurtz G; Lemesle G; Caspar T; Morel O; Dumonteil N; Duhamel A; Paris C; Dupont-Prado A; Legendre P; Mouquet F; Marchant B; Hermoire S; Corseaux D; Moussa K; Manchuelle A; Bauchart JJ; Loobuyck V; Caron C; Zawadzki C; Leroy F; Bodart JC; Staels B; Goudemand J; Lenting PJ; Susen S
N Engl J Med; 2016 Jul; 375(4):335-44. PubMed ID: 27464202
[TBL] [Abstract][Full Text] [Related]
3. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
[TBL] [Abstract][Full Text] [Related]
4. CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement.
Kibler M; Marchandot B; Messas N; Caspar T; Vincent F; Von Hunolstein JJ; Grunebaum L; Reydel A; Rauch A; Crimizade U; Kindo M; Hoang Minh T; Trinh A; Petit-Eisenmann H; De Poli F; Leddet P; Jesel L; Ohlmann P; Susen S; Van Belle E; Morel O
Thromb Haemost; 2018 May; 118(5):893-905. PubMed ID: 29590670
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
[TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand syndrome in aortic stenosis.
Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor and the aortic valve: Concepts that are important in the transcatheter aortic valve replacement era.
Ibrahim H; Rondina MT; Kleiman NS
Thromb Res; 2018 Oct; 170():20-27. PubMed ID: 30092557
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand Factor for Aortic Valve Intervention: From Bench to Real-Time Bedside Assessment.
Vincent F; Rauch A; Loobuyck V; Moussa M; Juthier F; Debry N; Jeanpierre E; Lenting PJ; Susen S; Van Belle E
Circ Res; 2018 May; 122(11):1499-1500. PubMed ID: 29798900
[No Abstract] [Full Text] [Related]
10. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
[TBL] [Abstract][Full Text] [Related]
11. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion.
Steinlechner B; Zeidler P; Base E; Birkenberg B; Ankersmit HJ; Spannagl M; Quehenberger P; Hiesmayr M; Jilma B
Ann Thorac Surg; 2011 May; 91(5):1420-6. PubMed ID: 21439546
[TBL] [Abstract][Full Text] [Related]
12. Disappearance of Angiodysplasia Following Transcatheter Aortic Valve Implantation in a Patient with Heyde's Syndrome: A Case Report and Review of the Literature.
Tsuchiya S; Matsumoto Y; Doman T; Fujiya T; Sugisawa J; Suda A; Sato K; Ikeda S; Shindo T; Kikuchi Y; Hao K; Takahashi J; Hatta W; Koike T; Masamune A; Saiki Y; Horiuchi H; Shimokawa H
J Atheroscler Thromb; 2020 Mar; 27(3):271-277. PubMed ID: 31378751
[TBL] [Abstract][Full Text] [Related]
13. Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
Pawlitschek F; Keyl C; Zieger B; Budde U; Beyersdorf F; Neumann FJ; Stratz C; Nührenberg TG; Trenk D
Thromb Haemost; 2018 Jan; 118(1):103-111. PubMed ID: 29304530
[TBL] [Abstract][Full Text] [Related]
14. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
[TBL] [Abstract][Full Text] [Related]
15. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.
Yamashita K; Yagi H; Hayakawa M; Abe T; Hayata Y; Yamaguchi N; Sugimoto M; Fujimura Y; Matsumoto M; Taniguchi S
J Atheroscler Thromb; 2016 Oct; 23(10):1150-1158. PubMed ID: 27052664
[TBL] [Abstract][Full Text] [Related]
16. Platelet function analyzer (PFA-100) as a useful tool for the prediction of transfusion requirements during aortic valve replacement.
Sucker C; Litmathe J; Feindt P; Zotz R
Thorac Cardiovasc Surg; 2011 Jun; 59(4):233-6. PubMed ID: 21412708
[TBL] [Abstract][Full Text] [Related]
17. Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosis.
Varghese SS; Hetu MF; Bowman M; Herr J; Al-Turki M; Jaff Z; James P; Malik P; Payne D; Johri AM
Haemophilia; 2023 Sep; 29(5):1306-1312. PubMed ID: 37428626
[TBL] [Abstract][Full Text] [Related]
18. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
[TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
[TBL] [Abstract][Full Text] [Related]
20. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study).
Blackshear JL; Wysokinska EM; Safford RE; Thomas CS; Stark ME; Shapiro BP; Ung S; Johns GS; Chen D
Am J Cardiol; 2013 Feb; 111(3):374-81. PubMed ID: 23168287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
